Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115863) titled 'Clinical study of Carrilizumab combined with Apatinib in prevention of postoperative recurrence of early hepatocellular carcinoma' on Dec. 31, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Medical Institution
Condition:
Hepatocellular carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Experimental group:55;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=303555
Disclaimer: Curated by HT Syndication....